SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (900)11/12/1998 9:51:00 PM
From: William Strop  Read Replies (2) | Respond to of 1972
 
Scott,

As stated in the new release, "The benefit derived by some patients and the lack of serious side effects further suggest its potential application in earlier disease stages."

Since it is common knowledge in the medical profession that early detection of diseases helps tremendously in the battle against them, why wouldn't using Allovectin-7 earlier in the disease cycle be helpful??

So, go ahead and get that clinical going.

Bill


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News